e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Biomarkers and lung function in airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transforming growth factor-ß1 and Matrix Metalloproteinase-9 as factors of airway remodeling among asthmatic patients
V. Kmyta (Sumy, Ukraine), L. Prystupa (Sumy, Ukraine)
Source:
International Congress 2018 – Biomarkers and lung function in airway disease
Session:
Biomarkers and lung function in airway disease
Session type:
Poster Discussion
Number:
5053
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Kmyta (Sumy, Ukraine), L. Prystupa (Sumy, Ukraine). Transforming growth factor-ß1 and Matrix Metalloproteinase-9 as factors of airway remodeling among asthmatic patients. 5053
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Transforming growth factor alpha produces airway remodelling and reduces airway distensibility
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Hepatocyte growth factor prevents airway remodelling in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003
Connective tissue growth factor and transforming growth factor β induces extracellular matrix in asthmatic airway smooth muscle
Source: Eur Respir J 2005; 26: Suppl. 49, 712s
Year: 2005
Fibroblast growth factor 23 and Klotho contribute to airway inflammation
Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018
Year: 2018
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006
Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006
Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-?1 in airway fibroblasts in asthma
Source: Eur Respir J 2014; 43: 464-473
Year: 2013
Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma
Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma
Year: 2004
Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma
Source: Eur Respir J 2003; 21: 804-809
Year: 2003
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Source: Eur Respir J 2006; 27: 957-963
Year: 2006
Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 92s
Year: 2001
Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Association of transforming growth factor-beta with asthmatic airway remodelling: a study using induced sputum and computed tomography
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006
Matrix metalloproteinase-9 (MMP-9) and transforming growth factor β1 (TGF β1) levels in induced sputum and serum samples of mild and severe asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001
Neutrophil vascular endothelial growth factor (VEGF) as a driving force for angiogenesis in bronchiectasis?
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
PP113 – Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood?
Source: ERS Lung Science Conference 2021
Year: 2021
The role of integrins in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 157-162
Year: 2008
Transforming growth factor beta induces Beclin-1 in pulmonary arterial endothelial cells
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept